Newsroom

Sorted by: Latest

-

Riassunto: AdvanCell riceve la prima fornitura di torio-228 ad attività elevata, evidenziando capacità e competenze industriali uniche, fondamentali per scalare la produzione di piombo-212 per terapie alfa mirate

SYDNEY e BOSTON--(BUSINESS WIRE)--AdvanCell, azienda radiofarmaceutica in fase clinica specializzata in terapie oncologiche alfa mirate, ha annunciato oggi di aver ricevuto la prima consegna di 228Th ad attività elevata, l'isotopo originario di 212Pb e un materiale di partenza essenziale nella produzione di 212Pb, un emettitore alfa, utilizzato nella fabbricazione di ADVC001, il prodotto di punta dell'azienda, e altre terapie con radioligandi a base di 212Pb in programma. Il testo originale del...
-

INNIO gewinnt renommierten Deutschen Nachhaltigkeitspreis 2026

JENBACH, Österreich--(BUSINESS WIRE)--Die INNIO Group hat den Deutschen Nachhaltigkeitspreis für Unternehmen 2026 gewonnen. INNIO wurde bei der 18. Preisvergabe in Düsseldorf als Sieger der Kategorie „Motoren und Turbinen“ im Bereich „Maschinen und Anlagen“ geehrt. Der Deutsche Nachhaltigkeitspreis zählt zu den renommiertesten Auszeichnungen für unternehmerische Verantwortung in Europa und orientiert sich an den Zielen der Agenda 2030 der Vereinten Nationen und damit an den zentralen Transforma...
-

INNIO wins prestigious German Sustainability Award 2026

JENBACH, Austria--(BUSINESS WIRE)--INNIO Group has been awarded the German Sustainability Award for Companies 2026. At the 18th annual ceremony in Düsseldorf, INNIO was named winner in the “Engines and Turbines” category within the “Machines and Installations” sector. Recognized as one of Europe’s most respected distinctions for corporate responsibility, the German Sustainability Award reflects the United Nations’ Agenda 2030 and thus on the key areas of transformation such as climate, biodiver...
-

World’s First Patients Successfully Treated With Novel Scarcell Therapeutics Therapy Using Gum Cells Designed to Relieve Knee Osteoarthritis

PARIS--(BUSINESS WIRE)--The first patients in the world have been treated with Scarcell Therapeutics' aGF Therapy using gum cells designed to relieve knee osteoarthritis....
-

EURONICS and NIQ Forge Strategic Collaboration to Elevate Retail Pricing Intelligence

NUREMBERG, Germany--(BUSINESS WIRE)--NIQ (NYSE: NIQ), a leading consumer intelligence company combined with GfK in 2023, has been selected by EURONICS, a leading global shopping cooperative in the Technical Consumer Goods (TCG) sector, to provide comprehensive Online Price Monitoring. NIQ's Online Price Monitoring provides insights into pricing dynamics by tracking item-level pricing across a defined data set. The system captures product information, matches items accurately, and ensures qualit...
-

3 Hit MangaPlaza Titles Coming to Print at Select U.S. Bookstores

OSAKA, Japan--(BUSINESS WIRE)--3 Hit MangaPlaza Titles Coming to Print at Select U.S. Bookstores...
-

Netcracker Completes Major Revenue Management Upgrade and Large-Scale Cloud Deployment for AIS

WALTHAM, Mass.--(BUSINESS WIRE)--Thai operator AIS goes live with Netcracker’s cloud-native BSS platform for B2C and B2B quad-play customers as part of a major upgrade....
-

SonicEdge and Earfab Partner to Shape the Future of Personalized Audio and Hearing Wellness

BINYAMINA-GIV’AT ADA, Israel--(BUSINESS WIRE)--SonicEdge, a pioneer in micro-acoustic innovation, today announced a strategic partnership with Earfab, the innovator of custom-fit hearing technology, to co-develop a new generation of personalized audio solutions that unite comfort, precision, and hearing safety. By combining SonicEdge’s high-performance MEMS speaker-in-chip technology with Earfab’s custom-fit eartips – crafted using its proprietary earfabSCAN 3D smartphone scanning platform – th...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: NewDay Partnership Master Issuer plc GBP 243,950,000.00 MATURING: 15-Jul-2026 ISIN: XS2646687272 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 17-Nov-2025 TO 15-Dec-2025 HAS BEEN FIXED AT 5.38 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 15-Dec-2025 WILL AMOUNT TO: GBP 1,006,008.90 PER GBP 243,950,000.00 DENOMINATION  ...
-

Samenvatting: Verimatrix ondertekent een overeenkomst voor de verkoop van XTD Assets (code- en applicatiebeveiliging) aan Guardsquare

AIX-EN-PROVENCE, Frankrijk & SAN DIEGO--(BUSINESS WIRE)--VERIMATRIX (Euronext Parijs: VMX, FR0010291245), een toonaangevende leverancier van beveiligingsoplossingen voor gebruikers voor een veiligere verbonden wereld, kondigt aan dat het een overeenkomst is aangegaan met het Belgische Guardsquare, de toonaangevende leverancier van beveiliging voor mobiele applicaties, waaraan het zijn Extended Threat Defense (XTD)-activa verkoopt. Deze bekendmaking is officieel geldend in de originele brontaal....